National Drug Policy Board
Download National Drug Policy Board full books in PDF, epub, and Kindle. Read online free National Drug Policy Board ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Committee for the Substance Abuse Coverage Study |
| Publisher | : National Academies Press |
| Total Pages | : 332 |
| Release | : 1992-01-01 |
| Genre | : Medical |
| ISBN | : 9780309043960 |
Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.
| Author | : United States. General Accounting Office |
| Publisher | : |
| Total Pages | : 36 |
| Release | : 1988 |
| Genre | : Drug abuse |
| ISBN | : |
| Author | : National Survey on Drug Use and Health (U.S.) |
| Publisher | : |
| Total Pages | : 288 |
| Release | : 2002 |
| Genre | : Drug abuse |
| ISBN | : |
| Author | : Thomas Babor |
| Publisher | : Oxford University Press |
| Total Pages | : 349 |
| Release | : 2018-07-03 |
| Genre | : Medical |
| ISBN | : 0192550276 |
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 483 |
| Release | : 2017-09-28 |
| Genre | : Medical |
| ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
| Author | : Office of the Surgeon General |
| Publisher | : Createspace Independent Publishing Platform |
| Total Pages | : 420 |
| Release | : 2017-08-15 |
| Genre | : |
| ISBN | : 9781974580620 |
All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 329 |
| Release | : 1996-10-01 |
| Genre | : Medical |
| ISBN | : 0309175380 |
Drug abuse persists as one of the most costly and contentious problems on the nation's agenda. Pathways of Addiction meets the need for a clear and thoughtful national research agenda that will yield the greatest benefit from today's limited resources. The committee makes its recommendations within the public health framework and incorporates diverse fields of inquiry and a range of policy positions. It examines both the demand and supply aspects of drug abuse. Pathways of Addiction offers a fact-filled, highly readable examination of drug abuse issues in the United States, describing findings and outlining research needs in the areas of behavioral and neurobiological foundations of drug abuse. The book covers the epidemiology and etiology of drug abuse and discusses several of its most troubling health and social consequences, including HIV, violence, and harm to children. Pathways of Addiction looks at the efficacy of different prevention interventions and the many advances that have been made in treatment research in the past 20 years. The book also examines drug treatment in the criminal justice setting and the effectiveness of drug treatment under managed care. The committee advocates systematic study of the laws by which the nation attempts to control drug use and identifies the research questions most germane to public policy. Pathways of Addiction provides a strategic outline for wise investment of the nation's research resources in drug abuse. This comprehensive and accessible volume will have widespread relevanceâ€"to policymakers, researchers, research administrators, foundation decisionmakers, healthcare professionals, faculty and students, and concerned individuals.
| Author | : Western Hemisphere Drug Poli Commission |
| Publisher | : |
| Total Pages | : 118 |
| Release | : 2020-12-03 |
| Genre | : |
| ISBN | : |
On behalf of the Western Hemisphere Drug Policy Commission, and pursuant to Public Law114-323, we are pleased to submit the following report with our review of US foreign policy inthe Americas to reduce the flow of illicit drugs and the damage associated with drug trafficking.Our recommendations provide a roadmap for cost-effective, evidence-based drug controlpolicies that will address their fundamental objective: reducing the number of American liveslost to drugabuse.Drug trafficking is a complex, constantly evolving threat that requires a comprehensive butflexible approach. We believe our recommendations will enable the US government toimplement a long-term, inter-agency strategy that can be adapted to the needs of our LatinAmerican partners. It also provides for an evidence-based approach based on relevantindicators and periodic assessments.Over the past year and a half, the Western Hemisphere Drug Policy (WHDPC) has heldmeetings and workshops with US officials, foreign diplomats, and independent experts in thefields of drug control and foreign assistance. Commissioners and staff members also traveledto Colombia, Mexico, and Central America to assess US policies in the field.The findings and recommendations in this report have been agreed to unanimously by the eightMembers of the Commission. We call on Congress and the President to consider this reportfully and take action to address the ongoing tragedy of illegal drug abuse and trafficking
| Author | : United States. Congress. House. Select Committee on Narcotics Abuse and Control |
| Publisher | : |
| Total Pages | : 88 |
| Release | : 1988 |
| Genre | : Drug control |
| ISBN | : |
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 350 |
| Release | : 2013-03-21 |
| Genre | : Medical |
| ISBN | : 0309260558 |
Problems stemming from the misuse and abuse of alcohol and other drugs are by no means a new phenomenon, although the face of the issues has changed in recent years. National trends indicate substantial increases in the abuse of prescription medications. These increases are particularly prominent within the military, a population that also continues to experience long-standing issues with alcohol abuse. The problem of substance abuse within the military has come under new scrutiny in the context of the two concurrent wars in which the United States has been engaged during the past decade-in Afghanistan (Operation Enduring Freedom) and Iraq (Operation Iraqi Freedom and Operation New Dawn). Increasing rates of alcohol and other drug misuse adversely affect military readiness, family readiness, and safety, thereby posing a significant public health problem for the Department of Defense (DoD). To better understand this problem, DoD requested that the Institute of Medicine (IOM) assess the adequacy of current protocols in place across DoD and the different branches of the military pertaining to the prevention, screening, diagnosis, and treatment of substance use disorders (SUDs). Substance Use Disorders in the U.S. Armed Forces reviews the IOM's task of assessing access to SUD care for service members, members of the National Guard and Reserves, and military dependents, as well as the education and credentialing of SUD care providers, and offers specific recommendations to DoD on where and how improvements in these areas could be made.
